Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;42(7):947-952.
doi: 10.1038/s41372-022-01382-w. Epub 2022 Apr 11.

Antimicrobial utilization in very-low-birth-weight infants: association with probiotic use

Joseph Y Ting  1   2 , Eugene W Yoon  3 , Carlos A Fajardo  4 , Thierry Daboval  5 , Valérie Bertelle  6 , Prakesh S Shah  7   8 ; Canadian Neonatal Network (CNN) Investigators
Collaborators, Affiliations

Antimicrobial utilization in very-low-birth-weight infants: association with probiotic use

Joseph Y Ting et al. J Perinatol. 2022 Jul.

Abstract

Objective: To examine the association between probiotic use and antimicrobial utilization.

Study design: We retrospectively evaluated very-low-birth-weight (VLBW) infants admitted to tertiary neonatal intensive care units in Canada between 2014 and 2019. Our outcome was antimicrobial utilization rate (AUR) defined as number of days of antimicrobial exposure per 1000 patient-days.

Result: Of 16,223 eligible infants, 7279 (45%) received probiotics. Probiotic use rate increased from 10% in 2014 to 68% in 2019. The AUR was significantly lower in infants who received probiotics vs those who did not (107 vs 129 per 1000 patient-days, aRR = 0.89, 95% CI [0.81, 0.98]). Among 13,305 infants without culture-proven sepsis or necrotizing enterocolitis ≥Stage 2, 5931 (45%) received probiotics. Median AUR was significantly lower in the probiotic vs the no-probiotic group (78 vs 97 per 1000 patient-days, aRR = 0.85, 95% CI [0.74, 0.97]).

Conclusion: Probiotic use was associated with a significant reduction in AUR among VLBW infants.

PubMed Disclaimer

References

    1. Osowicki J, Gwee A, Noronha J, Britton PN, Isaacs D, Lai TB, et al. Australia-wide point prevalence survey of antimicrobial prescribing in neonatal units: how much and how good? Pediatr Infect Dis J. 2015;34:e185–190. - DOI
    1. Patel SJ, Oshodi A, Prasad P, Delamora P, Larson E, Zaoutis T, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J. 2009;28:1047–51. - DOI
    1. Pammi M, Hollister E, Neu J. Gut injury and the microbiome in neonates. Clin Perinatol. 2020;47:369–82. - DOI
    1. Schwartz DJ, Langdon AE, Dantas G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med. 2020;12:82. https://doi.org/10.1186/s13073-020-00782-x . - DOI - PubMed - PMC
    1. Ting JY, Synnes A, Roberts A, Deshpandey A, Dow K, Yoon E, et al. Association of antibiotic utilization and neonatal outcomes in very-low-birth-weight infants without proven sepsis. JAMA Pediatrics. 2016;170:1181–7. - DOI

Publication types

Substances